Navigation Links
Stryker to Present at Investor Conferences
Date:8/22/2008

KALAMAZOO, Mich., Aug. 22 /PRNewswire-FirstCall/ -- Stryker Corporation (NYSE: SYK) announced today that it will participate in the following investor conferences:

September 3, 2008 - 9:45 a.m. Eastern Time

Thomas Weisel Partners Healthcare Conference 2008

Boston, Massachusetts

September 17, 2008 - 9:30 a.m. Eastern Time

Merrill Lynch Global Pharmaceutical Conference 2008

London, England

Simultaneous webcasts of the Company's presentations will be available on Stryker's website at http://www.stryker.com via the Investor page. The presentation for the Thomas Weisel Partners conference will be archived for 30 days and the Merrill Lynch conference will be archived for 14 days.

Certain statements made in the presentations may constitute forward- looking statements. They will be based upon management's current expectations and will be subject to various risks and uncertainties that could cause the Company's actual results to differ materially from those expressed or implied in such statements. In addition to factors that may be discussed in the presentations, such factors include, but are not limited to: pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for the Company's products; regulatory actions; unanticipated issues arising in connection with clinical studies and otherwise that affect U.S. Food and Drug Administration approval of new products; changes in reimbursement levels from third-party payors; a significant increase in product liability claims; changes in economic conditions that adversely affect the level of demand for the Company's products; changes in foreign exchange markets; changes in financial markets; and changes in the competitive environment. Additional information concerning these and other factors is contained in the Company's filings with the U.S. Securities and Exchange Commission, including the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; and endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. For more information about Stryker, please visit the company web site at http://www.stryker.com.


'/>"/>
SOURCE Stryker Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Stryker To Present at Investor Conference
2. Stryker to Present at Investor Conferences
3. Stryker to Present at Investor Conference
4. Stryker to Provide Webcast and Telephone Access to Annual Shareholder Meeting
5. Stryker to Host Conference Call on April 17, 2008
6. Northwestern Memorial Hospitals Steven J. Stryker MD Unveils Campaign With Empower Public Relations
7. Stryker Announces Share Repurchase Program
8. Stryker to Present at Investor Conference
9. Stryker to Host Analyst Meeting
10. VIDEO from Medialink and Stryker: New Alternative to Hip Replacement Surgery
11. Stryker to Present at Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... While James Earl Jones is known for myriad ... a show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a ... plummeted in large part due to early detection. Like any other disease, treatments have ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients ... can now take advantage of a cosmetic procedure known as Carbon Dioxide ... reduces the appearance of age spots, fine lines, uneven coloration, wrinkles, scarring, ...
(Date:12/2/2016)... ... , ... Lori G. Cohen and Sara K. Thompson , ... American Conference Institute’s 21st Drug & Medical Device Litigation Conference , taking place ... conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation ...
(Date:12/2/2016)... AL (PRWEB) , ... December 02, 2016 , ... ... from across the Dothan-Wiregrass Area in Alabama are expected to attend the UNCF ... Schmitz, will help provide scholarship funds for area students and operating support to ...
(Date:12/2/2016)... ... ... The annual time frame to change Medicare health and prescription drug coverage, known ... Medicare beneficiaries who are looking to switch from their current plan to a Medicare ... during this period order for their new policy to go into effect in 2017. ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , December 2, 2016 ... "In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, ... Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - ... market is valued at USD 60.22 Billion in ... a CAGR of 5.5% during the forecast period ...
(Date:12/2/2016)... , December 2, 2016 ... Awards Committee honored excellence in research, development and innovation ... The gala dinner was held in the presence of ... the Russian Federation , Natalia Sanina, ... Mikhail Murashko , Head of Roszdravnadzor, National Service ...
(Date:12/2/2016)... RICHMOND, British Columbia , December 2, 2016 ... Produkt, den INSTI HIV-Selbsttest, bei den Mitgliedern des Apothekenbundes von Kenia eingeführt. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ...
Breaking Medicine Technology: